Guardian Life Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-233
| Closed | -$87K | – | 377 |
|
|
2019
Q4 | $87K | Hold |
233
| – | – | 0.02% | 206 |
|
|
2019
Q3 | $65K | Buy |
233
+7
| +3% | +$1.95K | 0.01% | 267 |
|
|
2019
Q2 | $71K | Hold |
226
| – | – | 0.01% | 246 |
|
|
2019
Q1 | $93K | Buy |
226
+7
| +3% | +$2.88K | 0.01% | 192 |
|
|
2018
Q4 | $82K | Buy |
219
+6
| +3% | +$2.25K | 0.01% | 191 |
|
|
2018
Q3 | $86K | Hold |
213
| – | – | 0.01% | 204 |
|
|
2018
Q2 | $73K | Buy |
213
+36
| +20% | +$12.3K | 0.01% | 214 |
|
|
2018
Q1 | $61K | Sell |
177
-71
| -29% | -$24.5K | 0.01% | 216 |
|
|
2017
Q4 | $93K | Buy |
248
+74
| +43% | +$27.8K | 0.02% | 208 |
|
|
2017
Q3 | $78K | Buy |
174
+3
| +2% | +$1.35K | 0.01% | 172 |
|
|
2017
Q2 | $84K | Sell |
171
-119
| -41% | -$58.5K | 0.01% | 151 |
|
|
2017
Q1 | $112K | Hold |
290
| – | – | 0.02% | 191 |
|
|
2016
Q4 | $106K | Hold |
290
| – | – | 0.02% | 202 |
|
|
2016
Q3 | $117K | Hold |
290
| – | – | 0.01% | 206 |
|
|
2016
Q2 | $101K | Buy |
290
+2
| +0.7% | +$697 | 0.01% | 243 |
|
|
2016
Q1 | $104K | Sell |
288
-75
| -21% | -$27.1K | 0.01% | 231 |
|
|
2015
Q4 | $197K | Sell |
363
-89
| -20% | -$48.3K | 0.02% | 173 |
|
|
2015
Q3 | $210K | Buy |
452
+122
| +37% | +$56.7K | 0.02% | 188 |
|
|
2015
Q2 | $168K | Buy |
330
+10
| +3% | +$5.09K | 0.01% | 195 |
|
|
2015
Q1 | $144K | Sell |
320
-100
| -24% | -$45K | 0.01% | 218 |
|
|
2014
Q4 | $172K | Hold |
420
| – | – | 0.02% | 225 |
|
|
2014
Q3 | $151K | Sell |
420
-21
| -5% | -$7.55K | 0.02% | 235 |
|
|
2014
Q2 | $125K | Hold |
441
| – | – | 0.01% | 268 |
|
|
2014
Q1 | $132K | Hold |
441
| – | – | 0.01% | 259 |
|
|
2013
Q4 | $121K | Sell |
441
-483
| -52% | -$133K | 0.01% | 272 |
|
|
2013
Q3 | $289K | Buy |
924
+6
| +0.7% | +$1.88K | 0.02% | 231 |
|
|
2013
Q2 | $206K | Buy |
+918
| New | +$206K | 0.02% | 283 |
|